Effect of vaccine shortages on timeliness of pneumococcal conjugate vaccination: Results from the 2001-2005 National Immunization Survey

Pediatrics

Volumn 120, Issue 5, 2007, Pages

  Smith, Philip J ^a,c   Nuorti, J Pekka ^a   Singleton, James A ^a   Zhao, Zhen ^a   Wolter, Kirk M ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

Author keywords

Childhood immunization; Surveillance and monitoring

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; STREPTOCOCCUS INFECTION; UNITED STATES; VACCINATION;

CHILD, PRESCHOOL; COHORT STUDIES; HEALTH CARE SURVEYS; HUMANS; INFANT; PNEUMOCOCCAL VACCINES; TIME FACTORS; UNITED STATES; VACCINATION; VACCINES, CONJUGATE;

EID: 36048973178     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0037     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-9):1-38. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr4909a1. htm. Accessed April 9, 2007
2. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366
3. Centers for Disease Control and Prevention. Notice to readers: updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep. 2004; 53:177-178. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5308a5.htm. Accessed April 9, 2007
4. Centers for Disease Control and Prevention. Notice to readers: decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:783-784. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/ mm5036a3.htm. Accessed April 9, 2007
5. Centers for Disease Control and Prevention. Notice to readers: updated recommendations on the use of pneumococcal conju gate vaccine in a setting of vaccine shortage - Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2001;50:1140-1142. Available at: www.cdc.gov/mmwr/preview/ mmwrhtml/mm5050a4.htm. Accessed April 9, 2007
6. Centers for Disease Control and Prevention. Notice to readers: pneumococcal conjugate vaccine shortage resolved. MMWR Morb Mortal Wkly Rep. 2003;52:446-447. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/ mm5219a6.htm. Accessed April 9, 2007
7. Centers for Disease Control and Prevention. Notice to readers: limited supply of pneumococcal conjugate vaccine: suspension of recommendation for fourth dose. MMWR Morb Mortal Wkly Rep. 2004;53:108 -109. Available at http://www.cdc.gov/MMWR/preview/mmwrhtml/mm5305a6.htm. Accessed September 8, 2007
8. Centers for Disease Control and Prevention. Notice to readers: pneumococcal conjugate vaccine shortage resolved. MMWR Morb Mortal Wkly Rep. 2004;53:851- 852. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/ mm5336a8.htm. Accessed April 9, 2007
9. Zell ER, Ezzati-Rice TM, Battaglia MP, Wright RA. The National Immunization Survey: the methodology of a vaccination surveillance system. Pub Health Rep. 2000;115:65-77
10. Smith PJ, Battaglia MP, Huggins VJ, et al. Overview of the sampling design and statistical methods used in the National Immunization Survey. Am J Prev Med. 2001;20(4 suppl):17-24
11. Smith PJ, Rao JNK, Battaglia MP, et al. Compensating for nonresponse bias in the national immunization survey using response propensities. Vital Health Stat. 2001;(133):2. Available at: www.cdc.gov/nchs/data/series/sr_02/ sr02_133.pdf. Accessed April 9, 2007
12. Smith PJ, Hoaglin DC, Battaglia MP, et al. Statistical Methodology of the National Immunization Survey: 1994-2002. Vital Health Stat. 2005;(138):2. Available at: www.cdc.gov/nchs/data/series/sr_02/sr02_138.pdf. Accessed April 9, 2007
13. American Association for Public Opinion Research. Standard Definitions. Ann Arbor, MI: American Association for Public Opinion Research; 1998. Available at: www.aapor.org/pdfs/standarddefs_3.1.pdf. Accessed April 9, 2007
14. SAS Institute Inc. SAS/STAT Users Guide, Version 9. Cary, NC: SAS Institute Inc; 2003
15. Smith PJ, Zhao Z, Wolter KM, Singleton JA, Nuorti PJ. Age-period-cohort analyses of public health data collected from independent serial cross-sectional complex probability sample surveys. In: Proceedings of the Section on Survey Research Methods. Alexandria, VA: American Statistical Association; 2007
16. Centers for Disease Control and Prevention. Recommended childhood and adolescent immunization schedule: United States, 2006. Morb Mortal Wkly Rep. 2006;54:Q1-Q4
17. Whitney CG, Pilishvili T, Farley MM, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006;368:1495-1502
18. Reingold A, Hadler J, Farley MM. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease: United States, 1998-2003. MMWR Morbid Mortal Wkly Rep. 2005; 54:893-897. Available at: http://www.cdc.gov/ mmwr/preview/mmwrhtml/mm5436a1.htm. Accessed September 8, 2007
19. Chu SY, Barker LB, Smith PJ. Racial and Ethnic Disparities in Preschool Immunizations, United States, 1996-2001. Am J Public Health. 2004;94:973-977
20. Smith PJ, Stevenson J, Chu SY. Associations between childhood vaccination coverage, insurance type, and breaks in health insurance coverage. Pediatrics. 2006;117:1972-1978
21. Smith PJ, Santoli JM, Chu SY, Ochoa DQ, Rodewald LE. The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program. Pediatrics. 2005;116:130-139
22. Broder KR, MacNeil A, Malone S, et al. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations. Pediatrics. 2005;115:1479-1487
23. Centers for Disease Control and Prevention. Notice to readers: updated recommendation of the pneumococcal conjugate vaccine in a setting of vaccine shortage: Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2001;50: 1040-1042. Available at: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5050a4.htm. Accessed September 8, 2007
24. Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal vaccine: suspension of recommendation for third and fourth dose. MMWR Morb Mortal Wkly Rep. 2004;53:177-178. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5308a5.htm. Accessed September 8, 2007
25. Bartlett DL, Ezzati-Rice TM, Stokley, S, Zhao, Z. Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates. Am J Prev Med. 2001;20(4 suppl):25-27
26. Centers for Disease Control and Prevention. Notice to readers: shortage of tetanus and diphtheria toxoids. MMWR Morb Mortal Wkly Rep. 2000;49:1029 -1030. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm4945a3.htm. Accessed September 8, 2007
27. Centers for Disease Control and Prevention. Notice to readers: delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. MMWR Morb Mortal Wkly Rep. 2000;49:619-622. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/ mm4927a4. htm. Accessed September 8, 2007
28. Centers for Disease Control and Prevention. Notice to readers: shortage of varicella and measles, mumps and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2002;51: 190-197. Available at: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5109a6.htm. Accessed September 8, 2007
29. Centers for Disease Control and Prevention. Notice to readers: limited supply of meningococcal conjugate vaccine recommendation to defer vaccination of persons aged 11-12 years. MMWR Morb Mortal Wkly Rep. 2006;55:1-5. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm55d520a1.htm. Accessed September 8, 2007
30. Rodewald LE, Orenstein WA, Mason DD, Cochi SL. Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention. Clin Infect Dis. 2006;42:S104-S110
31. United States General Accounting Office. Childhood Vaccines: Ensuring an Adequate Supply Poses Continuing Challenges. Washington, DC: US General Accounting Office; 2002:1-42. Available at: http://www.gao.gov/new.items/d02987. pdf. Accessed September 8, 2007
32. Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics. 2000;106:1097-1102
33. Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics. 2006;118(5). Available at: www.pediatrics.org/cgi/content/full/118/5/e1287
34. Briss PA, Rodewald LE, Hinman AR, et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18(suppl 1):97-140
35. Diekema DS and the Committee on Bioethics. Responding to parental refusals of immunization of children. Pediatrics. 2005;115:1428-1431